Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
The DOI matches its Crossref record; 173 of the 174 references it cites were found in a registry or an index.
Abstract
Many studies have shown the central importance of the co-receptors CD28, inducible costimulatory molecule (ICOS) and cytotoxic T lymphocyte antigen 4 (CTLA4) in the regulation of many aspects of T-cell function. CD28 and ICOS have both overlapping and distinct functions in the positive regulation of T-cell responses, whereas CTLA4 negatively regulates the response. The signalling pathways that underlie the function of each of the co-receptors indicate their shared and unique properties and provide compelling hints of functions that are as yet uncovered. Here, we outline the shared and distinct signalling events that are associated with each of the co-receptors and provide unifying concepts that are related to signalling functions of these co-receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
Citations
Cites
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914 · cited 1×
“CTLA4-deficient mice develop massive lymphoadenopathy, autoimmunity and early deat”
BackgroundLymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766 · cited 1×
“CTLA4-deficient mice develop massive lymphoadenopathy, autoimmunity and early deat”
BackgroundSH2 domains recognize specific phosphopeptide sequences
Zhou, S. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,631
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,603
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222 · cited 1×
“Co-ligation of CTLA4 with TCR, or with TCR and CD28 or TCR and ICOS inhibits proliferatio”
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
Three-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,902
Research works printed but not linked: 7
- Marinari, B. et al. Vav cooperates with CD28 to induce NF-κB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur. J. Immunol. 32, 447–456 (2002). This study shows that dominant-negative forms of VAV can effectively block the induction of nuclear factor-κB (NF-κB) activation through a pathway that involves RAC1. · DOI · Paper page
- Ghaffari-Tabrizi, N. et al. Protein kinase C-θ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur. J. Immunol. 29, 132–142 (1999). · DOI · Paper page
- Tuosto, L. et al. Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-κB activation. Eur. J. Immunol. 30, 2445–2454 (2000). · DOI · Paper page
- Dimitratos, S. D., Woods, D. F., Stathakis, D. G. & Bryant, P. J. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays 21, 912–921 (1999). · DOI · Paper page
- Schneider, H., da Rocha Dias, S., Hu, H. & Rudd, C. E. A regulatory role for cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling. Eur. J. Immunol. 31, 2042–2050 (2001). · DOI · Paper page
- Nakaseko, C. et al. Cytotoxic lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med. 190, 765–774 (1999). · DOI · Paper page
- Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131–2142 (1998). · doi:10.1002/(sici)1521-4141(199807)28:07<2131::aid-immu2131>3.0.co;2-q
Cited by
Items 201–300 of 393
Programmed cell death 1 ligand (PD-L1) on T cells generates Treg suppression from memory
Kazanova, A., & Rudd, C. E. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001272 · Cited by 22
“In terms of intracellular signaling, the pathway involved the AKT–mTOR and MAP kinase pathways consistent with previous studies showing that CTLA-4 binds to phosphatidyl inositol 3-kinase (PI3K) which in turn activates AKT–mTOR [9], and where the truncation of PI3K signaling can induce Tregs [10].”
ResultSelf-citationOno, T., Yanagawa, Y., Iwabuchi, K., Nonomura, K., & Onoé, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02627.x · Cited by 21
Marriott, C. L., Carlesso, G., Herbst, R., & Withers, D. R. (2015) · European Journal of Immunology · doi:10.1002/eji.201445421 · Cited by 20
Bozzi, A., Reis, B. S., do Prado, F. L. S., Pedroso, E. P., Leite, M. F., & Goes, A. M. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01501.x · Cited by 20
Inaba‐Inoue, S., Numoto, N., Ogawa, S., Morii, H., Ikura, T., Abe, R., Ito, N., & Oda, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.755173 · Cited by 23
“The p85 subunit of PI3K consists of an SH3 domain, a RhoGAP domain, and two SH2 domains, which are designated as nSH2 and cSH2 for the N- and C-terminal SH2 domains, respectively.”
BackgroundInfluential4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation
Shin, S. M., Kim, Y. H., Choi, B. K., Kwon, P. M., Lee, H., & Kwon, B. S. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006619 · Cited by 22
Mochel, J. P., Ekker, S. C., Johannes, C. M., Jergens, A. E., Allenspach, K., Bourgois‐Mochel, A., Knouse, M., Benzekry, S., Wierson, W. A., LeBlanc, A. K., et al. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0322-1 · Cited by 25
Altering immune tolerance therapeutically: the power of negative thinking
Prud’homme, G. J. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0803394 · Cited by 20
“[25, 66 ]). CTLA-4 is induced following TCR engagement but is mostly stored in lysosomes, where it is degraded in the TABLE 2. B Cell Hyperactivity and SLE-Like Disease in”
BackgroundBúfalo, N. E., dos Santos, R. B., Rocha, A. G., Rabi, L. T., Romaldini, J. H., & Ward, L. S. (2020) · Endocrine · doi:10.1007/s12020-020-02337-x · Cited by 20
“CTLA4 plays a key role in the negative regulation of T-cell activation and proliferation, competing with CD28 for binding to the B7–1/B7–2 receptor [5].”
BackgroundHigo, K., Oda, M., Morii, H., Takahashi, J., Harada, Y., Ogawa, S., & Abe, R. (2014) · Immunological Investigations · doi:10.3109/08820139.2013.875039 · Cited by 20
“The mechanisms by which these adaptor proteins associate with CD28 have been extensively studied by many groups including ourselves (Rudd & Schneider, 2003).”
BackgroundWagner, D. H. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00208 · Cited by 24
“CD28 is expressed on most naïve, activated, and memory T cells; ICOS and CTLA-4 are expressed on activated T cells and subsets of memory cells (36).”
BackgroundHaematopoietic stem cell transplantation for autoimmune disease: limits and future potential
Brenner, M. K. (2004) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.05.004 · Cited by 19
T-Cell Costimulatory Blockade in Organ Transplantation
Maltzman, J. S., & Turka, L. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015537 · Cited by 20
“The cytoplasmic region (41 aa in human and 38 aa in mouse) has no intrinsic enzymatic activity, but contains several protein interaction motifs (Rudd and Schneider 2003).”
BackgroundTumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy
Prakash, A., Gates, T. J., Zhao, X., Wangmo, D., & Subramanian, S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108332 · Cited by 23
Fish Uses CTLA-4 Immune Checkpoint to Suppress mTORC1-Controlled T-Cell Glycolysis and Immunity
Zhang, J., Wei, X., Zhang, Q., Jiao, X., Li, K., Geng, M., Cao, Y., Wang, D., Cheng, J., & Yang, J. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300599 · Cited by 17
Wang, L., Jiang, Z., Qiu, H., Tang, W., Duan, T., & Wang, L. (2015) · Europe PMC (PubMed Central) · Cited by 18
Ahmadi, S., Rostamzade, J., Khosravi, D., Shariati, P., & Shakiba, N. (2013) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2013.1929.1935 · Cited by 19
Molecular Dynamics of Co-signal Molecules in T-Cell Activation
Saito, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_5 · Cited by 18
Yang, J., Lickliter, J. D., Hillson, J., Means, G., Sanderson, R. J., Carley, K., Tercero, A., Manjarrez, K. L., Wiley, J. R., & Peng, S. L. (2021) · Clinical and Translational Science · doi:10.1111/cts.12983 · Cited by 19
Nukada, Y., Okamoto, N., Konakahara, S., Tezuka, K., Ohashi, K., Mizuno, K., & Tsuji, T. (2006) · International Immunology · doi:10.1093/intimm/dxl115 · Cited by 18
“Its expression on T cells is induced by T-cell activation upon antigen recognition via both the TCR‐CD3 complex and a second co-stimulatory signaling mechanism through CD28 (9, 10 ).”
BackgroundZhang, Y., Wei, Z., Dong, H. F., Zhou, J., Yuan, J., Ni, B., Wu, Y., Han, C., & Tian, Y. (2020) · RNA Biology · doi:10.1080/15476286.2020.1862567 · Cited by 21
“CTLA-4, also known as CD152, is a protein receptor that functions as an immune checkpoint and contributes to immune inhibitory functions [51,52].”
BackgroundDillon, S. R., Evans, L. S., Lewis, K. E., Debrot, S., Blair, T. C., Mudri, S., Kleist, K. N., Levin, S. D., Bhandari, J. G., Garrett, L., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42484 · Cited by 17
Maazi, H., Shirinbak, S., den Boef, L. E., Fallarino, F., Volpi, C., Nawijn, M. C., & van Oosterhout, A. J. M. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12041 · Cited by 17
Aragoneses-Fenoll, L., Ojeda, G., Montes‐Casado, M., Acosta‐Ampudia, Y., Dianzani, U., Portolés, P., & Rojo, J. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00332 · Cited by 18
Luff, D. H., Wojdyła, K., Oxley, D., Chessa, T. A. M., Hudson, K., Hawkins, P. T., Stephens, L., Barry, S. T., & Okkenhaug, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631271 · Cited by 19
Wesseling-Rozendaal, Y. J. W., van Doorn, A., Willard-Gallo, K. E., & van de Stolpe, A. (2022) · Cancers · doi:10.3390/cancers14030490 · Cited by 21
Chye, A., Allen, I., Barnet, M. B., & Burnett, D. L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.894015 · Cited by 17
Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand
Lim, H.-S., Cordoba, S., Dushek, O., Goyette, J., Taylor, A., Rudd, C. E., & van der Merwe, P. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500707 · Cited by 20
Self-citationOgawa, S., Watanabe, M., Sakurai, Y., Inutake, Y., Watanabe, S., Tai, X., & Abe, R. (2013) · International Immunology · doi:10.1093/intimm/dxt028 · Cited by 18
Peter, H. H., & Warnatz, K. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.s61 · Cited by 19
“Most regulated genes were induced by T-cell receptor signalling alone, but were strongly augmented by CD28 and ICOS costimulation.”
BackgroundInfluentialMukherjee, S., Ahmed, A., & Nandi, D. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1104644 · Cited by 23
High Resolution Crystal Structure of the Grb2 SH2 Domain with a Phosphopeptide Derived from CD28
Higo, K., Ikura, T., Oda, M., Morii, H., Takahashi, J., Abe, R., & Ito, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074482 · Cited by 16
“A number of signaling molecules such as Grb2 and phosphatidylinositol 3-kinase (PI3K) bind to the cytoplasmic region of CD28 and activate CD28-mediated costimulatory signaling [9,10].”
Backgrounddel Rio, M., Seebach, J. D., Fernández‐Renedo, C., & Rodríguez-Barbosa, J.-I. (2013) · Xenotransplantation · doi:10.1111/xen.12049 · Cited by 17
“The cytoplasmic tail of CTLA-4 contains an YVKM motif, a typical ITIM; however, the molecules and the mechanism involved in this negative signal pathway have not been fully elucidated [23].”
BackgroundTajima, N., Tezuka, K., Tanimoto, A., Miyai, A., Tanimoto, M., Maruhashi, J., & Watanabe, Y. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.06.004 · Cited by 17
Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278)
Acosta‐Ampudia, Y., Zafra, M. P., Ojeda, G., Bernardone, I. S., Dianzani, U., Portolés, P., & Rojo, J. M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0606-1 · Cited by 18
“CD28 has a YMNM cytoplasmic motif that binds distinct adapter protein or enzymes as well as PI3-kinases [ 2 , 63], whereas so far only PI3-kinases have been found associated to ICOS (this work and [9‐13]).”
BackgroundCytotoxic T-lymphocyte antigen 4–immunogolbulin in rheumatoid arthritis
Kremer, J. M. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.02.002 · Cited by 16
Vermijlen, D., Seynaeve, C., Luo, D., Kruhøffer, M., Eizirik, D. L., Orntoft, T. F., & Wisse, E. (2004) · European Journal of Immunology · doi:10.1002/eji.200324712 · Cited by 17
CD28 Exerts Protective and Detrimental Effects in a Pulmonary Model of Paracoccidioidomycosis
Felonato, M., Pina, A., Bernardino, S., Loures, F. V., de Araújo, E. F., & Calich, V. L. G. (2010) · Infection and Immunity · doi:10.1128/iai.00297-10 · Cited by 16
“CTLA-4 is a costimulatory molecule of which the main function is to attenuate the expansion and cytokine production of recently activated T cells (67).”
BackgroundCoreceptors and Their Ligands in Epithelial γδ T Cell Biology
Witherden, D. A., Johnson, M. D., & Havran, W. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00731 · Cited by 16
“Unlike αβ T cells, epithelial-resident γδ T cells do not express CD4, CD8 (although the CD8aa homodimer is expressed by some γδ IEL), or CD28 (61), however, a number of other molecules have recently been described to participate in the activation of these cells.”
BackgroundInfluentialCD28 Signaling Drives Notch Ligand Expression on CD4 T Cells
Mitra, A., Shanthalingam, S., Sherman, H. L., Singh, K., Canakci, M., Torres, J. A., Lawlor, R. G., Ran, Y., Golde, T. E., Miele, L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00735 · Cited by 15
Li, K., Qian, S., Huang, M., Chen, M., Peng, L., Liu, J., Xu, W., & Xu, J. (2021) · American Journal of Translational Research · Cited by 21
Lymphocytes T régulateurs, atopie et asthme : un nouveau concept en trois dimensions
Mamessier, É., Botturi, K., VERVLOET, D., & Magnan, A. (2005) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(05)85482-8 · Cited by 15
Transitioning from native to synthetic receptors: broadening T-cell engineering and beyond
Li, Y., Liu, Y., & Lin, X. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01304-8 · Cited by 18
Immunotherapy for head and neck cancer: Fundamentals and therapeutic development
Okano, S. (2024) · Auris Nasus Larynx · doi:10.1016/j.anl.2024.05.001 · Cited by 15
The Adaptation Model of Immunity
Manjili, M. H. (2013) · Immunotherapy · doi:10.2217/imt.13.157 · Cited by 14
Premature Terminal Differentiation Protects from Deregulated Lymphocyte Activation by ITK-Syk
Bach, M. P., Hug, E., Werner, M., Holch, J. W., Sprissler, C., Pechloff, K., Zirlik, K., Zeiser, R., Dierks, C., Ruland, J., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300420 · Cited by 14
Primary Cutaneous Follicular Helper T-Cell Lymphoma: A Case Series and Review of the Literature
Wang, J., Nguyen, G. H., Ruan, J., & MAGRO, C. M. J. (2017) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000000695 · Cited by 15
“It forms homodimers and plays an important role in cell–cell signaling, immune responses, and regulation of cell proliferation.(19) ICOS contributes to the acquisition of expression of CXCR5 on T cells.”
BackgroundUbiquitin ligases in T cell activation and autoimmunity
Zhang, J. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.003 · Cited by 15
Chen, P.-L., Fann, C. S. J., Chang, C.-C., Wu, I.-L., Chiu, W.-Y., Lin, C.-Y., Yang, W.-S., & Chang, T.-C. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364445 · Cited by 14
Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer
Xiong, Y., He, L., & Jing, F. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.10.018 · Cited by 14
“CTLA-4 plays a pivotal role in the negative regulation of T cell proliferation and activation by competing with CD28 for B7-1/B7-2 binding [6].”
BackgroundAnnibaldi, A., Sajeva, A., Muscolini, M., Ciccosanti, F., Corazzari, M., Piacentini, M., & Tuosto, L. (2008) · European Journal of Immunology · doi:10.1002/eji.200737854 · Cited by 14
Grzywnowicz, M., & Giannopoulos, K. (2012) · Acta Haematologica Polonica · doi:10.1016/s0001-5814(12)32008-2 · Cited by 21
Mukherjee, S., Mukhopadhyay, D., Ghosh, S., Barbhuiya, J. N., Das, N. K., & Chatterjee, M. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0215-8 · Cited by 13
“The engagement of CD28 on the surface of T-cells with CD80 or CD86 expressed on APCs provides a co-stimulatory signal essential for T-cell proliferation, differentiation, and cytokine secretion [19].”
BackgroundDaga, N., Servaas, N. H., Kisand, K. E., Moonen, D. P. I., Arnold, C., Reyes‐Palomares, A., Kaleviste, E., Kingo, K., Kuuse, R., Ulst, K., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114810 · Cited by 15
ICOS Gene Polymorphism May Be Associated with Pemphigus
Narbutt, J., Lesiak, A., Klich, I., Torzecka, J. D., Sysa‐Jędrzejowska, A., & Mlynarski, W. M. (2010) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2010.09061 · Cited by 11
“CD28 and ICOS increase T-cell action, whereas CTLA4 is considered a negative regulatory molecule.(7) It was revealed that CTLA4 polymorphisms may affect CTLA4 intracellular distribution and influence the production of interleukin (IL)-2 and T-cell proliferation.”
BackgroundCTLA4 A49G Polymorphism Shows Significant Association With Glioma Risk in a Chinese Population
Wu, Q., Zhan, X., Dou, T., Chen, H., Fan, W., Zhou, K., Zhang, H., Zheng, H., Cai, Y., Zhao, Y., et al. (2010) · Biochemical Genetics · doi:10.1007/s10528-010-9398-0 · Cited by 11
“CTLA-4, a second receptor of the costimulatory factors B7-1 and B7-2, is a key negative regulator of T-cell activation (Egen et al. 2002; Rudd and Schneider 2003; Sharpe and Freeman 2002; Alegre et al. 2001).”
BackgroundFranko, J., & Levine, A. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0808505 · Cited by 11
“Not surprisingly, ICOS costimulation enhances TCR-induced PI-3K lipid kinase activity as well as the phosphorylation of the downstream serine/threonine protein kinase Akt [28].”
BackgroundInfluentialIs deficient tolerance the true paradigm for atopic diseases?
Magnan, A., & Humbert, M. J. C. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02392.x · Cited by 11
Charge-based immunoreceptor signalling in health and disease
Shi, X., He, X., & Xu, C. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01105-6 · Cited by 11
“Beyond CD3, LCK can phosphorylate other BRS-containing immuno-receptors, such as CD28, ICOS, CTLA4 and CD5 52,96,97 .”
Iiyama, M., Numoto, N., Ogawa, S., Kuroda, M., Morii, H., Abe, R., Ito, N., & Oda, M. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.12.002 · Cited by 10
CD 28 signals the differential control of regulatory T cells and effector T cells
Mikami, N., & Sakaguchi, S. (2014) · European Journal of Immunology · doi:10.1002/eji.201444513 · Cited by 13
“The PI3K/Akt pathway contributes to T-cell survival, activation and cytokine production [11, 12].”
BackgroundInfluentialJylhävä, J., Eklund, C., Jylhä, M. K., Hervonen, A., & Hurme, M. (2010) · Biogerontology · doi:10.1007/s10522-010-9274-7 · Cited by 10
“At the cellular level, however, ICOS and CD28 share more overlapping signalling pathways with each other than with CTLA-4 (Carreno and Collins 2002; Rudd and Schneider 2003 ), supporting the possibility that with ageing, the expression of these costimulators could be discretely modified via signal transduction.”
BackgroundMultiple Receptor-Ligand Interactions Direct Tissue-Resident γδ T Cell Activation
Witherden, D. A., Ramirez, K., & Havran, W. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00602 · Cited by 11
Li, Y., Chan, E. Y., & Katze, M. G. (2007) · Virology · doi:10.1016/j.virol.2007.04.020 · Cited by 11
“, 2006) and the overall immune response (Rudd and Schneider, 2003), was down-regulated on day 4 but not on day 6 p.”
ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
O’Brien, C. A., & Harris, T. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228251 · Cited by 11
Mukherjee, S., Ahmed, A., Malu, S., & Nandi, D. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0505260 · Cited by 13
“Activation with anti-CD3 and anti-CD28 increased the proportion of cycling cells but reduced the proportion of hypodiploid cells [1, 3].”
BackgroundCalvo‐Barreiro, L., Upadhyay, S., & Gabr, M. T. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100256 · Cited by 9
Immunobiology and host response.
Koelle, D. M. (2007) · Cambridge University Press eBooks · Cited by 9
Huang, Y. S., Wang, M., Zhao, X., & Shi, Q. (2018) · Genomics · doi:10.1016/j.ygeno.2018.11.018 · Cited by 9
Aragoneses-Fenoll, L., Montes‐Casado, M., Ojeda, G., García-Paredes, L., Arimura, Y., Yagi, J., Dianzani, U., Portolés, P., & Rojo, J. M. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a0220-127r · Cited by 9
Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling
Skånland, S. S., & Taskén, K. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801660 · Cited by 9
“Peptide array and peptide synthesis Soluble Arg9CD28186–215 and Arg9CD28186–215 pY191/pY209 were synthesized with Fmoc-protection chemistry on an Intavis MultiPep robot (Intavis Bioanalytical Instruments AG, Cologne, Germany).”
BackgroundInfluentialMolecular Regulation of Cytoskeletal Rearrangements During T Cell Signalling
Stradal, T. E. B., Pusch, R., & Kliche, S. (2006) · Springer eBooks · doi:10.1007/400_022 · Cited by 10
“This requires not only TCR-proximal signalling but also costimulation through CD28 with CD80 or CD86 (Acuto and Michel 2003; Rudd and Schneider 2003).”
BackgroundCD28 Sensitizes TCR Ca2+ Signaling during Ag-Independent Polarization of Plasma Membrane Rafts
Byrum, J. N., Komen, J. S. V., & Rodgers, W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300485 · Cited by 8
“Because Pro(187) and Pro(190) in CD28 recruits and activates Lck (25, 26), we interrogated the role of Lck in forming AISs.”
BackgroundCD8+ T cell killing of MHC class I–deficient tumors
Rudd, C. E. (2023) · Nature Cancer · doi:10.1038/s43018-023-00606-y · Cited by 8
Self-citationNo major effect of theCD28/CTLA4/ICOSgene region on susceptibility to primary sclerosing cholangitis
Wiencke, K., Boberg, K. M., Donaldson, P. T., Harbo, H. F., Ling, V., Schrumpf, E., & Spurkland, A. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500377870 · Cited by 8
“Activation of the ICOS molecule modulates T-cell activity while CTLA4 competes with CD28 for binding to the antigen presenting cell (APC) and activation through CTLA-4 down-regulates the T-cell response [9].”
BackgroundImmune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection
Righi, I., Trabattoni, D., Rosso, L., Vaira, V., & Clerici, M. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106860 · Cited by 7
“Interestingly, CD80/CD86 can also bind CTLA-4 and in this case the interaction results in the delivery of a potent inhibitory signal, as indicated by the observation that CTLA-4-deficient mice show a lethal phenotype characterized by a strong pro-inflammatory profile [12 – 14].”
Akieda, Y., Wakamatsu, E., Nakamura, T. Y., Ishida, Y., Ogawa, S., & Abe, R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402591 · Cited by 8
“These are involved in CD28-mediated costimulatory signal transduction (13).”
BackgroundManagement of checkpoint inhibitor-associated renal toxicities
Vanoverbeke, L., & Sprangers, B. (2017) · Expert Review of Quality of Life in Cancer Care · doi:10.1080/23809000.2017.1369045 · Cited by 7
“Many co-stimulatory molecules have been described which can be both activating or inhibiting [9,10].”
BackgroundVav1 GEF activity is required for T cell mediated allograft rejection
Haubert, D., Li, J., Saveliev, A., Calzascia, T., Sutter, E., Metzler, B., Kaiser, D., Tybulewicz, V. L. J., & Weckbecker, G. (2012) · Transplant Immunology · doi:10.1016/j.trim.2012.03.003 · Cited by 8
“Vav1 has been shown to link CD28 costimulation to T cell activation [34–36].”
Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
Stein, C., Schubert, I. A., & Fey, G. H. (2012) · Antibodies · doi:10.3390/antib1010088 · Cited by 11
“The cytotoxic T-lymphocyte antigen-4 (CTLA-4), an inhibitory surface receptor, binds with higher affinity to CD80 and CD86 than CD28, and thus promotes the inactivation of T-cells [62,63].”
Liu, D., Suchard, S. J., Nadler, S., & Ford, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130490 · Cited by 8
“However, these CTLA-4 Ig fusion proteins bind the CD80 and CD86 ligands and thus block CD28 costimulatory signals, but also inhibit CTLA-4 mediated coinhibitory signals [14].”
BackgroundCTLA-4 Regulation of T Cell Function via RAP-1-Mediated Adhesion
Schneider, H., Valk, E., Dias, S. D. R., Wei, B., & Rudd, C. E. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-34132-3_9 · Cited by 9
Self-citationDynamic Tuning of T Cell Receptor Specificity by Co-Receptors and Costimulation
van den Berg, H. A., & Sewell, A. K. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7725-0_3 · Cited by 7
“as members of the TNF receptor family are expressed in activated T cells and are important in regulating the size of the expansion [ 56 , 57].”
BackgroundTajima, N., Tezuka, K., Tanaka, M., Tanimoto, M., Miyai, A., Takeshima, H., & Watanabe, Y. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.05.002 · Cited by 6
Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell Immunity
Issa, M. E., & Rudd, C. E. (2021) · Journal of Cellular Immunology · doi:10.33696/immunology.3.115 · Cited by 8
“PD-1 and CTLA-4 inhibit AKT activation via different mechanisms resulting in enhanced GSK-3 inhibitory functions.”
BackgroundInfluentialSelf-citationRegulation of T-cell migration by co-stimulatory molecules
David, R., & Marelli‐Berg, F. M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351114 · Cited by 6
Wilson, L., Lewis, K. E., Evans, L. S., Dillon, S. R., & Pepple, K. L. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.3.27 · Cited by 5
Modulating immune response for the prevention and treatment of type 1 diabetes
Vohidova, D., Desai, P., Lozano, A. M., & Veiseh, O. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1715863 · Cited by 6
“Inducible co-stimulatory molecule (ICOS) plays a critical role in positively regulating T cell function, and its elevated expression is linked to an increase in circulating peripheral helper T cells (Tph) (57, 58).”
Dual immune checkpoint blockade strategies for cancer therapy
Liu, Y., Yadav, U. P., Chen, C., & Wang, P. (2026) · Cell investigation. · doi:10.1016/j.clnves.2026.100064 · Cited by 7
Prediction of Relapse After Antithyroid Drugs Withdrawal: A Narrative Review
Wang, P. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.102346 · Cited by 6
“SNP exon 1 + 49 A/G (rs231775) of the CTLA-4 gene in the afferent signal of costimulatory molecules, and three other risk alleles (rs745307, rs11569309, and rs3765457) at the CD40 in the efferent signal, were found to be risk alleles for recurrence.”
BackgroundInfluentialCan Molecular Imaging Measure T-cell Activation?
Choyke, P. L. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1146 · Cited by 5
Vatankhah, F., Salimi, N., Khalaji, A., & Baradaran, B. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109526 · Cited by 5
T Cell Activation and Function: Role of Signal Strength
Ahmed, A., & Nandi, D. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7725-0_4 · Cited by 6
CD28 family of receptors inter-connect in the regulation of T-cells
Krueger, J., Jules, F., Rieder, S. A., & Rudd, C. E. (2017) · Receptors & Clinical Investigation · doi:10.14800/rci.1581 · Cited by 6
“Phosphorylated YMNM binds to the SH2 domains of phosphatidyl inositol 3 kinase (PI3K) and Grb2 [13, 14].”
BackgroundSelf-citationImmune Checkpoints and Their Inhibition in T-Cell Lymphomas
Seňavová, J., Rajmonová, A., Heřman, V., Jura, F., Velasova, A., Hamová, I., Tkachenko, A. S., Kupcová, K., & Havránek, O. (2024) · Folia Biologica · doi:10.14712/fb2024070030123 · Cited by 5
Jiang, N., Wen, Z., Tao, H., & Liao, H. (2025) · Biological Procedures Online · doi:10.1186/s12575-025-00262-9 · Cited by 4
Wang, L., Li, Y., Wang, N., Huang, X., Cao, S., & Zhou, R. (2019) · International Journal of Immunogenetics · doi:10.1111/iji.12470 · Cited by 4
Papadimitriou, M., Liakouli, Z., & PAPADIMITRIOU, C. A. (2021) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2021.138 · Cited by 9
Ighid, N., Akil, S. E., Elouilamine, E., & Izaabel, E. H. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101513 · Cited by 4
Jammal, N., Pan, E. Y., Hurwitz, M. E., & Abramovitz, R. B. (2019) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155219854797 · Cited by 4
“Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) is another checkpoint protein on T cells that results in negative regulation of T effector cell activity but is also expressed on T regulatory cells.(10) Although the mechanisms are not clearly defined, antibody binding to CTLA-4 appears to both activate effector T…”
Background
Metadata
- Authors
- Rudd, C. E., & Schneider, H.
- Affiliations
- Hammersmith Hospital (GB)
- Corresponding author
- Rudd, Christopher E.
- ORCID
- Rudd, Christopher E.
- Venue
- Nature Reviews Immunology
- Published
- 2003-07
- Volume
- 3
- Issue
- 7
- Pages
- 544-556
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2001716606
- Cited by
- 392
- References
- 174
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 12 · 2023: 9 · 2022: 17 · 2021: 15 · 2020: 16 · 2019: 14 · 2018: 13 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 9 · 2013: 19 · 2012: 13
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, ICOS, CTLA-4, T cell activation, T cell costimulation, T cell tolerance, signaling pathways
- MeSH terms
- Abatacept, Amino Acid Sequence, Animals, Antigens, Differentiation, T-Lymphocyte, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, T-Lymphocytes, Signal Transduction, NF-kappa B, Protein Serine-Threonine Kinases, CD28 Antigens, Immunoconjugates, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, MAP Kinase Kinase Kinase 1, Proto-Oncogene Proteins c-akt, Proto-Oncogene Proteins c-vav, Inducible T-Cell Co-Stimulator Protein, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.